Aurora A Inhibitor I (TC-S 7010) is primarily used in cancer research and therapy development. It specifically targets and inhibits the Aurora A kinase, an enzyme involved in cell division and proliferation. By blocking this enzyme, it disrupts the growth and division of cancer cells, making it a potential candidate for treating various types of cancers, particularly those with overactive Aurora A kinase. Researchers utilize this compound to study its effects on tumor growth and to explore its potential in combination therapies with other anticancer agents. Its application is significant in preclinical studies aimed at understanding the role of Aurora A in cancer progression and developing targeted treatments.